Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elaine Patricia Kuhn
Observed names:
Elaine Kuhn,
Elaine P Kuhn,
Elaine P. Kuhn
Institutions:
Dartmouth–Hitchcock Medical Center,
Dartmouth Health,
Dartmouth Cancer Center
Observed institutions:
Dartmouth College,
Dartmouth–Hitchcock Medical Center,
Harvard University,
Dartmouth Health,
Dartmouth Cancer Center
ORCID:
0000-0001-9348-4611
Observed ORCID:
0000-0001-9348-4611
OpenAlex ID:
A5042736261
Transient commensal clonal interactions can drive tumor metastasis
2020
·
Suha Naffar-Abu Amara
, Hendrik J. Kuiken
, et al.
·
Nature Communications
·
45
PDF
Application of Artificial Intelligence in Symptom Monitoring in Adult Cancer Survivorship: A Systematic Review
2024
·
Sanam Tabataba Vakili
, Darren Haywood
, et al.
·
JCO Clinical Cancer Informatics
·
41
PDF
A multi-model approach integrating whole-slide imaging and clinicopathologic features to predict breast cancer recurrence risk
2024
·
Manu Goyal
, Jonathan D. Marotti
, et al.
·
npj Breast Cancer
·
30
PDF
Preventing metastatic recurrence in low-risk ER/PR + breast cancer patients—a retrospective clinical study exploring the evolving challenge of persistence with adjuvant endocrine therapy
2023
·
Elaine P. Kuhn
, Jonathan Pirruccello
, et al.
·
Breast Cancer Research and Treatment
·
4
PDF
SWIVEL: A randomized phase II trial of switching medications versus guideline-directed interventions for adjuvant aromatase inhibitor side effects in breast cancer patients.
2026
·
Elaine Patricia Kuhn
, Isabella Marchal
, et al.
·
Journal of Clinical Oncology
·
1
A Large Multicenter Real-World Evidence (RWE) Analysis of Autoimmune (AI) Diseases and Lymphoma: Histologic Associations, Disease Characteristics, Survival, and Prognostication
2021
·
Jordan Carter
, Adam J. Olszewski
, et al.
·
Blood
·
1
4 A survey of shared decision-making activities and care management during transitions from cancer treatment to survivorship care
2026
·
Christine Gunn
, Mia St. Angelo
, et al.
PDF
Metastatic Hormone Receptor+ Breast Cancer at ASCO 2026: Endocrine Resistance, Precision Monitoring, and Emerging Sequencing Strategies
2026
·
Francois-Clement Bidard
, Nicholas Turner
, et al.
·
Oncology The American Medical Journal
PDF
The Antibody-Drug Conjugate Glembatumumab Vedotin (CDX-011) and Its Use in the Treatment of Breast Cancer
2025
·
Elaine Kuhn
, Nancy Chan
, et al.
·
AAPS advances in the pharmaceutical sciences series
Cell Surface Lipoprotein Lipase Enzyme as A Prognostic Indicator in B-Cell Chronic Lymphocytic Leukemia
2023
·
Caleb J. Yelton
, Caleb J. Yelton
, et al.
·
Annals of Clinical Oncology
PDF
Management of adjuvant endocrine therapy (AET) side effects in patients with breast cancer: A single cancer center experience.
2023
·
Elaine Patricia Kuhn
, Jonathan P. Pirruccello
, et al.
·
Journal of Clinical Oncology
Abstract P1-13-06: The influence of the oncotype DX breast recurrence score on persistence to endocrine therapy in patients with low-risk ER/PR+ invasive breast cancer
2022
·
Jonathan Pirruccello
, Elaine Kuhn
, et al.
·
Cancer Research
Show more works
View as search
Works count:
12
Citation count:
122
H-index:
4
I10-index:
3
Year
Topic
Type